Glucose-only versus insulin-dextrose therapy for hyperkalaemia in non-diabetic adults

Phase 2, randomised, open-label trial of dextrose, human insulin, calcium gluconate and salbutamol in hyperkalemia (2 arms), sponsored by The University of Queensland. Primary endpoints: Incidence of hypoglycaemia and Mean change in serum potassium from baseline. Planned start Feb 2026; status: not yet recruiting.